Gottheimer caught taking blood money from J & J

We caught the culprits in action!  Thanks to the investigative reporting of Herb Jackson, the Washington Correspondent for the Bergen Record, we caught the Johnson & Johnson corporation's political action committee in the act of buying congressional candidate Josh Gottheimer.  From the Record (March 2, 2016): 

The political action committee of health products giant Johnson & Johnson hosted a Washington fund-raiser on Wednesday for Josh Gottheimer, the Democrat challenging Rep. Scott Garrett, according to an invitation obtained by The Record.

...It does not appear New Brunswick-based Johnson & Johnson’s PAC made any contributions to congressional challengers in the 2014 election, according data compiled by the Center for Responsive Politics. J&J’s committee did not give to Garrett in that election, either, and does not appear to have given to him so far in this cycle either, Federal Election Commission records show...

An aide confirmed Pallone, the top-ranking Democrat on the House Energy & Commerce Committee, which oversees a significant part of health insurance policy, was a featured guest at the J&J event for Gottheimer. According to the invitation, “suggested contribution levels” were $2,500 for PAC co-hosts, $1,000 for PAC supporters and $500 for individuals.

There was no immediate response to a message seeking comment from Johnson & Johnson. Amounts raised will be disclosed in quarterly reports due in April.

Gottheimer, a one-time speech writer for President Bill Clinton who recently stepped down from his job as a corporate strategist at Microsoft to focus on the campaign full-time, had $1.3 million in his campaign account on Dec. 31, the second-highest amount of any House challenger in the country.

The Johnson & Johnson money event for candidate Gottheimer comes just one week after the corporate giant lost a $72 million lawsuit to a woman who died from ovarian cancer after using Johnson & Johnson baby talc for feminine hygiene.  Time Magazine (March 2, 2016) takes up the story from here:

Many parents were shocked to learn that a Missouri jury recently ordered Johnson & Johnson to pay $72 million to the family of Jacqueline Fox, whose death by ovarian cancer was linked to her daily use of talcum-based Johnson’s Baby Powder and Shower to Shower products. You know the product—that sweet baby scent, the soft puff of powder.

For decades, Fox used these talc powders on her most sensitive body parts. And for decades, according to the case, Johnson & Johnson knew about the cancer link but failed to warn consumers.

Did we read that right?  Johnson & Johnson has known "for decades" that their BABY POWDER (yes, the stuff we put on infants) causes cancer "but failed to warn customers."  What corporate dirtball scumbags!

And Josh Dirtheimer, eh Gottheimer, is down with that? 

The same day Dirtheimer was trousering big sweaty wads of cash from the dirtball lobbyists for these corporate scumbags, a brave woman was on the front page of the New York Post(March 2, 2016) telling how she turned down a million dollar bribe from Johnson & Johnson to hush up her story:

I turned down $1M from Johnson & Johnson, and blew the whistle instead

Cosmetics giant Johnson & Johnson was last week ordered by a Missouri jury to pay $72 million in damages to the family of a woman whose death from ovarian cancer was linked to her decades-long use of the company’s talc-based Baby Powder and Shower to Shower products. Ovarian cancer survivor Deane Berg, 58, a physician’s assistant from Sioux Falls, SD, believes the judgment is a great victory. Here, Berg tells The Post’s Jane Ridley her story.

When I first noticed spotting between my periods in the fall of 2006 at the age of 49, I chalked it up to impending menopause. But my instinct as a physician’s assistant told me to get a second opinion from a gynecologist after my family practitioner told me I was fine.

So, that December, I went to Sanford Medical Center in Sioux Falls for an ultrasound. The technician was chatting away happily, but suddenly went quiet. “We’ll finish this up, and the nurse practitioner will come in to talk to you,” she said.

I got dressed, and the NP arrived. She put her hand on my knee. “Deane, I’m afraid something is wrong,” she said. “You’ve got a hemorrhagic ovary. We’re going to have one of the doctors review it.”

The next few days were a haze. I had both ovaries removed — the non-hemorrhagic one as a precaution. I was desperately upset but, after having two daughters, now ages 30 and 27, my child-bearing years were over.

But that was the least of my concerns. The results of the biopsy in January 2007 were devastating. As a health-care professional, I saw the words “bilateral carcinoma” on the pathology report, and my heart sank. I had stage 3 ovarian cancer, which had metastasized to some of my lymph nodes. The prognosis was not good, and I was facing a life expectancy of less than five years. I had a full hysterectomy within a week and prepared to undergo six months of painful chemotherapy.

Just a couple days after the surgery, I read some literature from my oncologist that included information from Gilda’s Club, the foundation created by friends of the late actress Gilda Radner. To my astonishment, it said that use of talcum powder has been implicated in the development of ovarian cancer.

There was no ovarian cancer in my family. I didn’t smoke. I wasn’t overweight. The one risk factor that stood out was my use of talcum powder...

Jurors found Johnson & Johnson liable for fraud, negligence and conspiracy after lawyers argued that the company knew about the dangers but did nothing to inform customers.

I’m so relieved that the issue is finally getting the attention it deserves. In 2013, I, too, sued Johnson & Johnson, and a federal jury found that its body powder products were a factor in my condition. Although I was surprised that the jury awarded me zero damages — South Dakota is a very conservative state, and there had to be a unanimous verdict on whether any compensation should be paid — it was never about the money. Earlier I had turned down a $1.3 million out-of-court settlement because I didn’t want to sign a confidentiality clause.

I believe that talc can cause ovarian cancer in women. Many apply it to their private parts, and talc particles travel to the ovaries through the cervix and line the uterus and fallopian tubes, resulting in toxic effects on the ovaries. In my opinion, talcum powder products should be withdrawn from the market and, until then, be clearly labeled indicating the risk.

No woman should have to go through what Mrs. Fox and I endured, along with thousands of other ovarian cancer sufferers. My life was consumed by chemotherapy and hospital visits. I had two ports put in my chest and abdomen for the IVs. Getting the chemo in my abdomen was the worst pain I’d ever experienced, even worse than childbirth. I suffered from hair loss, nausea, lack of appetite, and I would frequently throw up. I became anemic and could barely walk. Off work for sickness for six months, I couldn’t go out in public in case my immunity was compromised. Then my hearing started to go bad, a side effect of the chemotherapy. It was a living hell, but mercifully, about a year later, in 2008, I was told my cancer went into remission.

And my case paved the way for plaintiff lawyers to bring claims for hundreds of women who blame their ovarian cancer on exposure to talcum powder. As my lawyer said, I’m the equivalent of the first smokers who sued tobacco companies because of their lung cancer. The pioneers didn’t receive compensation, but the dangers and the conspiracy were finally exposed.

Now that Josh "lady-killer" Gottheimer has taken his (under current law) "legal" bribe from Johnson & Johnson, we have no doubt that he will try to use the money to attack his Republican opponent on "women's issues."  Well we have some news for you Dirtheimer, ovarian cancer IS a women's issue.  It's a big one. 

So give it back.  Return the "legal" bribe.  Don't take their money and you won't be indebted to the corporate pigs if you get to Congress.  Give it back.